Ziltivekimab
泽韦奇单抗
Report date: 2026/03/24 20:00:35
Base Information
Drug NameZiltivekimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[50]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesMedimmune Llc
China Registration ClassN/A
Develop Information
Active CompaniesEcri BvNovo Nordisk A/SVetter Pharma-Fertigung Gmbh & Co Kg +[7]
Inactive CompaniesN/A
Active Indications +[8]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A